Nathan Rice
Stock Analyst at Piper Sandler
(2.86)
# 1,849
Out of 5,081 analysts
60
Total ratings
50%
Success rate
8.12%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $38.75 | +23.87% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $33.01 | +27.23% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $28.40 | +23.24% | 9 | Oct 28, 2025 | |
| BFC Bank First | Maintains: Neutral | $137 → $142 | $125.61 | +13.05% | 9 | Oct 23, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $77.62 | -4.66% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $125.83 | -33.24% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $150.93 | +30.52% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $22.49 | -59.98% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $732.73 | -40.63% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $274.10 | -14.99% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $38.81 | +113.86% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $18.93 | -20.76% | 1 | Dec 19, 2019 |
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $38.75
Upside: +23.87%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $33.01
Upside: +27.23%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $28.40
Upside: +23.24%
Bank First
Oct 23, 2025
Maintains: Neutral
Price Target: $137 → $142
Current: $125.61
Upside: +13.05%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $77.62
Upside: -4.66%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $125.83
Upside: -33.24%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $150.93
Upside: +30.52%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $22.49
Upside: -59.98%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $732.73
Upside: -40.63%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $274.10
Upside: -14.99%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $38.81
Upside: +113.86%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $18.93
Upside: -20.76%